ANTI-MYOSTATIN

Clinical trials for ANTI-MYOSTATIN explained in plain language.

Never miss a new study

Get alerted when new ANTI-MYOSTATIN trials appear

Sign up with your email to follow new studies for ANTI-MYOSTATIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Muscle-Boosting drug shows promise for children with rare neuromuscular disease

Disease control Completed

This completed Phase 3 trial tested whether adding the experimental drug apitegromab to standard SMA treatments could improve muscle function in 188 children and young adults (ages 2-21) with later-onset spinal muscular atrophy. All participants were already receiving approved SM…

Matched conditions: ANTI-MYOSTATIN

Phase: PHASE3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

ANTI-MYOSTATIN

Get alerted when new ANTI-MYOSTATIN trials appear

Muscle-Boosting drug shows promise for children with rare neuromuscular disease